{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.666.5.1740","meta":{"versionId":"30","lastUpdated":"2016-03-31T01:00:12.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Immunocompromised Conditions</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://hl7.org/fhir/sid/icd-9-cm</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>200.20</td>\n              <td>Burkitt's tumor or lymphoma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.21</td>\n              <td>Burkitt's tumor or lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.22</td>\n              <td>Burkitt's tumor or lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.23</td>\n              <td>Burkitt's tumor or lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.24</td>\n              <td>Burkitt's tumor or lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.25</td>\n              <td>Burkitt's tumor or lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.26</td>\n              <td>Burkitt's tumor or lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.27</td>\n              <td>Burkitt's tumor or lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.28</td>\n              <td>Burkitt's tumor or lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.30</td>\n              <td>Marginal zone lymphoma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.31</td>\n              <td>Marginal zone lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.32</td>\n              <td>Marginal zone lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.33</td>\n              <td>Marginal zone lymphoma, intraabdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.34</td>\n              <td>Marginal zone lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.35</td>\n              <td>Marginal zone lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.36</td>\n              <td>Marginal zone lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.37</td>\n              <td>Marginal zone lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.38</td>\n              <td>Marginal zone lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.40</td>\n              <td>Mantle cell lymphoma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.41</td>\n              <td>Mantle cell lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.42</td>\n              <td>Mantle cell lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.43</td>\n              <td>Mantle cell lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.44</td>\n              <td>Mantle cell lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.45</td>\n              <td>Mantle cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.46</td>\n              <td>Mantle cell lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.47</td>\n              <td>Mantle cell lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.48</td>\n              <td>Mantle cell lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.50</td>\n              <td>Primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.51</td>\n              <td>Primary central nervous system lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.52</td>\n              <td>Primary central nervous system lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.53</td>\n              <td>Primary central nervous system lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.54</td>\n              <td>Primary central nervous system lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.55</td>\n              <td>Primary central nervous system lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.56</td>\n              <td>Primary central nervous system lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.57</td>\n              <td>Primary central nervous system lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.58</td>\n              <td>Primary central nervous system lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.60</td>\n              <td>Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.61</td>\n              <td>Anaplastic large cell lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.62</td>\n              <td>Anaplastic large cell lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.63</td>\n              <td>Anaplastic large cell lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.64</td>\n              <td>Anaplastic large cell lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.65</td>\n              <td>Anaplastic large cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.66</td>\n              <td>Anaplastic large cell lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.67</td>\n              <td>Anaplastic large cell lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.68</td>\n              <td>Anaplastic large cell lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.70</td>\n              <td>Large cell lymphoma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.71</td>\n              <td>Large cell lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.72</td>\n              <td>Large cell lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.73</td>\n              <td>Large cell lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.74</td>\n              <td>Large cell lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.75</td>\n              <td>Large cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.76</td>\n              <td>Large cell lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.77</td>\n              <td>Large cell lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>200.78</td>\n              <td>Large cell lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.00</td>\n              <td>Hodgkin's paragranuloma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.01</td>\n              <td>Hodgkin's paragranuloma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.02</td>\n              <td>Hodgkin's paragranuloma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.03</td>\n              <td>Hodgkin's paragranuloma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.04</td>\n              <td>Hodgkin's paragranuloma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.05</td>\n              <td>Hodgkin's paragranuloma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.06</td>\n              <td>Hodgkin's paragranuloma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.07</td>\n              <td>Hodgkin's paragranuloma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.08</td>\n              <td>Hodgkin's paragranuloma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.10</td>\n              <td>Hodgkin's granuloma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.11</td>\n              <td>Hodgkin's granuloma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.12</td>\n              <td>Hodgkin's granuloma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.13</td>\n              <td>Hodgkin's granuloma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.14</td>\n              <td>Hodgkin's granuloma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.15</td>\n              <td>Hodgkin's granuloma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.16</td>\n              <td>Hodgkin's granuloma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.17</td>\n              <td>Hodgkin's granuloma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.18</td>\n              <td>Hodgkin's granuloma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.20</td>\n              <td>Hodgkin's sarcoma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.21</td>\n              <td>Hodgkin's sarcoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.22</td>\n              <td>Hodgkin's sarcoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.23</td>\n              <td>Hodgkin's sarcoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.24</td>\n              <td>Hodgkin's sarcoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.25</td>\n              <td>Hodgkin's sarcoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.26</td>\n              <td>Hodgkin's sarcoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.27</td>\n              <td>Hodgkin's sarcoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.28</td>\n              <td>Hodgkin's sarcoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.40</td>\n              <td>Hodgkin's disease, lymphocytic-histiocytic predominance, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.41</td>\n              <td>Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.42</td>\n              <td>Hodgkin's disease, lymphocytic-histiocytic predominance, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.43</td>\n              <td>Hodgkin's disease, lymphocytic-histiocytic predominance, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.44</td>\n              <td>Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.45</td>\n              <td>Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.46</td>\n              <td>Hodgkin's disease, lymphocytic-histiocytic predominance, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.47</td>\n              <td>Hodgkin's disease, lymphocytic-histiocytic predominance, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.48</td>\n              <td>Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.50</td>\n              <td>Hodgkin's disease, nodular sclerosis, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.51</td>\n              <td>Hodgkin's disease, nodular sclerosis, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.52</td>\n              <td>Hodgkin's disease, nodular sclerosis, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.53</td>\n              <td>Hodgkin's disease, nodular sclerosis, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.54</td>\n              <td>Hodgkin's disease, nodular sclerosis, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.55</td>\n              <td>Hodgkin's disease, nodular sclerosis, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.56</td>\n              <td>Hodgkin's disease, nodular sclerosis, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.57</td>\n              <td>Hodgkin's disease, nodular sclerosis, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.58</td>\n              <td>Hodgkin's disease, nodular sclerosis, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.60</td>\n              <td>Hodgkin's disease, mixed cellularity, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.61</td>\n              <td>Hodgkin's disease, mixed cellularity, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.62</td>\n              <td>Hodgkin's disease, mixed cellularity, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.63</td>\n              <td>Hodgkin's disease, mixed cellularity, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.64</td>\n              <td>Hodgkin's disease, mixed cellularity, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.65</td>\n              <td>Hodgkin's disease, mixed cellularity, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.66</td>\n              <td>Hodgkin's disease, mixed cellularity, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.67</td>\n              <td>Hodgkin's disease, mixed cellularity, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.68</td>\n              <td>Hodgkin's disease, mixed cellularity, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.70</td>\n              <td>Hodgkin's disease, lymphocytic depletion, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.71</td>\n              <td>Hodgkin's disease, lymphocytic depletion, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.72</td>\n              <td>Hodgkin's disease, lymphocytic depletion, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.73</td>\n              <td>Hodgkin's disease, lymphocytic depletion, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.74</td>\n              <td>Hodgkin's disease, lymphocytic depletion, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.75</td>\n              <td>Hodgkin's disease, lymphocytic depletion, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.76</td>\n              <td>Hodgkin's disease, lymphocytic depletion, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.77</td>\n              <td>Hodgkin's disease, lymphocytic depletion, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.78</td>\n              <td>Hodgkin's disease, lymphocytic depletion, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.90</td>\n              <td>Hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.91</td>\n              <td>Hodgkin's disease, unspecified type, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.92</td>\n              <td>Hodgkin's disease, unspecified type, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.93</td>\n              <td>Hodgkin's disease, unspecified type, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.94</td>\n              <td>Hodgkin's disease, unspecified type, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.95</td>\n              <td>Hodgkin's disease, unspecified type, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.96</td>\n              <td>Hodgkin's disease, unspecified type, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.97</td>\n              <td>Hodgkin's disease, unspecified type, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>201.98</td>\n              <td>Hodgkin's disease, unspecified type, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.00</td>\n              <td>Nodular lymphoma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.01</td>\n              <td>Nodular lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.02</td>\n              <td>Nodular lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.03</td>\n              <td>Nodular lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.04</td>\n              <td>Nodular lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.05</td>\n              <td>Nodular lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.06</td>\n              <td>Nodular lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.07</td>\n              <td>Nodular lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.08</td>\n              <td>Nodular lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.70</td>\n              <td>Peripheral T cell lymphoma, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.71</td>\n              <td>Peripheral T cell lymphoma, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.72</td>\n              <td>Peripheral T cell lymphoma, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.73</td>\n              <td>Peripheral T cell lymphoma, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.74</td>\n              <td>Peripheral T cell lymphoma, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.75</td>\n              <td>Peripheral T cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.76</td>\n              <td>Peripheral T cell lymphoma, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.77</td>\n              <td>Peripheral T cell lymphoma, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.78</td>\n              <td>Peripheral T cell lymphoma, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.80</td>\n              <td>Other malignant lymphomas, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.81</td>\n              <td>Other malignant lymphomas, lymph nodes of head, face, and neck</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.82</td>\n              <td>Other malignant lymphomas, intrathoracic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.83</td>\n              <td>Other malignant lymphomas, intra-abdominal lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.84</td>\n              <td>Other malignant lymphomas, lymph nodes of axilla and upper limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.85</td>\n              <td>Other malignant lymphomas, lymph nodes of inguinal region and lower limb</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.86</td>\n              <td>Other malignant lymphomas, intrapelvic lymph nodes</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.87</td>\n              <td>Other malignant lymphomas, spleen</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.88</td>\n              <td>Other malignant lymphomas, lymph nodes of multiple sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>202.90</td>\n              <td>Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, unspecified site, extranodal and solid organ sites</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>203.00</td>\n              <td>Multiple myeloma, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>203.02</td>\n              <td>Multiple myeloma, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>203.10</td>\n              <td>Plasma cell leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>203.12</td>\n              <td>Plasma cell leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>204.00</td>\n              <td>Acute lymphoid leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>204.02</td>\n              <td>Acute lymphoid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>204.12</td>\n              <td>Chronic lymphoid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>204.20</td>\n              <td>Subacute lymphoid leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>204.22</td>\n              <td>Subacute lymphoid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>204.80</td>\n              <td>Other lymphoid leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>204.82</td>\n              <td>Other lymphoid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>204.90</td>\n              <td>Unspecified lymphoid leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>204.92</td>\n              <td>Unspecified lymphoid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.00</td>\n              <td>Acute myeloid leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.02</td>\n              <td>Acute myeloid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.10</td>\n              <td>Chronic myeloid leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.12</td>\n              <td>Chronic myeloid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.20</td>\n              <td>Subacute myeloid leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.22</td>\n              <td>Subacute myeloid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.80</td>\n              <td>Other myeloid leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.82</td>\n              <td>Other myeloid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.90</td>\n              <td>Unspecified myeloid leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>205.92</td>\n              <td>Unspecified myeloid leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.00</td>\n              <td>Acute monocytic leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.02</td>\n              <td>Acute monocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.10</td>\n              <td>Chronic monocytic leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.12</td>\n              <td>Chronic monocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.20</td>\n              <td>Subacute monocytic leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.22</td>\n              <td>Subacute monocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.80</td>\n              <td>Other monocytic leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.82</td>\n              <td>Other monocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.90</td>\n              <td>Unspecified monocytic leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>206.92</td>\n              <td>Unspecified monocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>207.20</td>\n              <td>Megakaryocytic leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>207.22</td>\n              <td>Megakaryocytic leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>207.80</td>\n              <td>Other specified leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>207.82</td>\n              <td>Other specified leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.00</td>\n              <td>Acute leukemia of unspecified cell type, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.02</td>\n              <td>Acute leukemia of unspecified cell type, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.10</td>\n              <td>Chronic leukemia of unspecified cell type, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.12</td>\n              <td>Chronic leukemia of unspecified cell type, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.20</td>\n              <td>Subacute leukemia of unspecified cell type, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.22</td>\n              <td>Subacute leukemia of unspecified cell type, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.80</td>\n              <td>Other leukemia of unspecified cell type, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.82</td>\n              <td>Other leukemia of unspecified cell type, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.90</td>\n              <td>Unspecified leukemia, without mention of having achieved remission</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>208.92</td>\n              <td>Unspecified leukemia, in relapse</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>238.75</td>\n              <td>Myelodysplastic syndrome, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>279.51</td>\n              <td>Acute graft-versus-host disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>279.53</td>\n              <td>Acute on chronic graft-versus-host disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>284.11</td>\n              <td>Antineoplastic chemotherapy induced pancytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>284.12</td>\n              <td>Other drug-induced pancytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>284.19</td>\n              <td>Other pancytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>288.00</td>\n              <td>Neutropenia, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>288.01</td>\n              <td>Congenital neutropenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>288.02</td>\n              <td>Cyclic neutropenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>288.03</td>\n              <td>Drug induced neutropenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>288.04</td>\n              <td>Neutropenia due to infection</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>288.09</td>\n              <td>Other neutropenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>289.53</td>\n              <td>Neutropenic splenomegaly</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.1740","version":"20160331","name":"Immunocompromised Conditions","status":"active","date":"2016-03-31T01:00:12-04:00","publisher":"Lantana EH Steward","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-9-cm","concept":[{"code":"200.20","display":"Burkitt's tumor or lymphoma, unspecified site, extranodal and solid organ sites"},{"code":"200.21","display":"Burkitt's tumor or lymphoma, lymph nodes of head, face, and neck"},{"code":"200.22","display":"Burkitt's tumor or lymphoma, intrathoracic lymph nodes"},{"code":"200.23","display":"Burkitt's tumor or lymphoma, intra-abdominal lymph nodes"},{"code":"200.24","display":"Burkitt's tumor or lymphoma, lymph nodes of axilla and upper limb"},{"code":"200.25","display":"Burkitt's tumor or lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"200.26","display":"Burkitt's tumor or lymphoma, intrapelvic lymph nodes"},{"code":"200.27","display":"Burkitt's tumor or lymphoma, spleen"},{"code":"200.28","display":"Burkitt's tumor or lymphoma, lymph nodes of multiple sites"},{"code":"200.30","display":"Marginal zone lymphoma, unspecified site, extranodal and solid organ sites"},{"code":"200.31","display":"Marginal zone lymphoma, lymph nodes of head, face, and neck"},{"code":"200.32","display":"Marginal zone lymphoma, intrathoracic lymph nodes"},{"code":"200.33","display":"Marginal zone lymphoma, intraabdominal lymph nodes"},{"code":"200.34","display":"Marginal zone lymphoma, lymph nodes of axilla and upper limb"},{"code":"200.35","display":"Marginal zone lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"200.36","display":"Marginal zone lymphoma, intrapelvic lymph nodes"},{"code":"200.37","display":"Marginal zone lymphoma, spleen"},{"code":"200.38","display":"Marginal zone lymphoma, lymph nodes of multiple sites"},{"code":"200.40","display":"Mantle cell lymphoma, unspecified site, extranodal and solid organ sites"},{"code":"200.41","display":"Mantle cell lymphoma, lymph nodes of head, face, and neck"},{"code":"200.42","display":"Mantle cell lymphoma, intrathoracic lymph nodes"},{"code":"200.43","display":"Mantle cell lymphoma, intra-abdominal lymph nodes"},{"code":"200.44","display":"Mantle cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"200.45","display":"Mantle cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"200.46","display":"Mantle cell lymphoma, intrapelvic lymph nodes"},{"code":"200.47","display":"Mantle cell lymphoma, spleen"},{"code":"200.48","display":"Mantle cell lymphoma, lymph nodes of multiple sites"},{"code":"200.50","display":"Primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites"},{"code":"200.51","display":"Primary central nervous system lymphoma, lymph nodes of head, face, and neck"},{"code":"200.52","display":"Primary central nervous system lymphoma, intrathoracic lymph nodes"},{"code":"200.53","display":"Primary central nervous system lymphoma, intra-abdominal lymph nodes"},{"code":"200.54","display":"Primary central nervous system lymphoma, lymph nodes of axilla and upper limb"},{"code":"200.55","display":"Primary central nervous system lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"200.56","display":"Primary central nervous system lymphoma, intrapelvic lymph nodes"},{"code":"200.57","display":"Primary central nervous system lymphoma, spleen"},{"code":"200.58","display":"Primary central nervous system lymphoma, lymph nodes of multiple sites"},{"code":"200.60","display":"Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites"},{"code":"200.61","display":"Anaplastic large cell lymphoma, lymph nodes of head, face, and neck"},{"code":"200.62","display":"Anaplastic large cell lymphoma, intrathoracic lymph nodes"},{"code":"200.63","display":"Anaplastic large cell lymphoma, intra-abdominal lymph nodes"},{"code":"200.64","display":"Anaplastic large cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"200.65","display":"Anaplastic large cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"200.66","display":"Anaplastic large cell lymphoma, intrapelvic lymph nodes"},{"code":"200.67","display":"Anaplastic large cell lymphoma, spleen"},{"code":"200.68","display":"Anaplastic large cell lymphoma, lymph nodes of multiple sites"},{"code":"200.70","display":"Large cell lymphoma, unspecified site, extranodal and solid organ sites"},{"code":"200.71","display":"Large cell lymphoma, lymph nodes of head, face, and neck"},{"code":"200.72","display":"Large cell lymphoma, intrathoracic lymph nodes"},{"code":"200.73","display":"Large cell lymphoma, intra-abdominal lymph nodes"},{"code":"200.74","display":"Large cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"200.75","display":"Large cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"200.76","display":"Large cell lymphoma, intrapelvic lymph nodes"},{"code":"200.77","display":"Large cell lymphoma, spleen"},{"code":"200.78","display":"Large cell lymphoma, lymph nodes of multiple sites"},{"code":"201.00","display":"Hodgkin's paragranuloma, unspecified site, extranodal and solid organ sites"},{"code":"201.01","display":"Hodgkin's paragranuloma, lymph nodes of head, face, and neck"},{"code":"201.02","display":"Hodgkin's paragranuloma, intrathoracic lymph nodes"},{"code":"201.03","display":"Hodgkin's paragranuloma, intra-abdominal lymph nodes"},{"code":"201.04","display":"Hodgkin's paragranuloma, lymph nodes of axilla and upper limb"},{"code":"201.05","display":"Hodgkin's paragranuloma, lymph nodes of inguinal region and lower limb"},{"code":"201.06","display":"Hodgkin's paragranuloma, intrapelvic lymph nodes"},{"code":"201.07","display":"Hodgkin's paragranuloma, spleen"},{"code":"201.08","display":"Hodgkin's paragranuloma, lymph nodes of multiple sites"},{"code":"201.10","display":"Hodgkin's granuloma, unspecified site, extranodal and solid organ sites"},{"code":"201.11","display":"Hodgkin's granuloma, lymph nodes of head, face, and neck"},{"code":"201.12","display":"Hodgkin's granuloma, intrathoracic lymph nodes"},{"code":"201.13","display":"Hodgkin's granuloma, intra-abdominal lymph nodes"},{"code":"201.14","display":"Hodgkin's granuloma, lymph nodes of axilla and upper limb"},{"code":"201.15","display":"Hodgkin's granuloma, lymph nodes of inguinal region and lower limb"},{"code":"201.16","display":"Hodgkin's granuloma, intrapelvic lymph nodes"},{"code":"201.17","display":"Hodgkin's granuloma, spleen"},{"code":"201.18","display":"Hodgkin's granuloma, lymph nodes of multiple sites"},{"code":"201.20","display":"Hodgkin's sarcoma, unspecified site, extranodal and solid organ sites"},{"code":"201.21","display":"Hodgkin's sarcoma, lymph nodes of head, face, and neck"},{"code":"201.22","display":"Hodgkin's sarcoma, intrathoracic lymph nodes"},{"code":"201.23","display":"Hodgkin's sarcoma, intra-abdominal lymph nodes"},{"code":"201.24","display":"Hodgkin's sarcoma, lymph nodes of axilla and upper limb"},{"code":"201.25","display":"Hodgkin's sarcoma, lymph nodes of inguinal region and lower limb"},{"code":"201.26","display":"Hodgkin's sarcoma, intrapelvic lymph nodes"},{"code":"201.27","display":"Hodgkin's sarcoma, spleen"},{"code":"201.28","display":"Hodgkin's sarcoma, lymph nodes of multiple sites"},{"code":"201.40","display":"Hodgkin's disease, lymphocytic-histiocytic predominance, unspecified site, extranodal and solid organ sites"},{"code":"201.41","display":"Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of head, face, and neck"},{"code":"201.42","display":"Hodgkin's disease, lymphocytic-histiocytic predominance, intrathoracic lymph nodes"},{"code":"201.43","display":"Hodgkin's disease, lymphocytic-histiocytic predominance, intra-abdominal lymph nodes"},{"code":"201.44","display":"Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of axilla and upper limb"},{"code":"201.45","display":"Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of inguinal region and lower limb"},{"code":"201.46","display":"Hodgkin's disease, lymphocytic-histiocytic predominance, intrapelvic lymph nodes"},{"code":"201.47","display":"Hodgkin's disease, lymphocytic-histiocytic predominance, spleen"},{"code":"201.48","display":"Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of multiple sites"},{"code":"201.50","display":"Hodgkin's disease, nodular sclerosis, unspecified site, extranodal and solid organ sites"},{"code":"201.51","display":"Hodgkin's disease, nodular sclerosis, lymph nodes of head, face, and neck"},{"code":"201.52","display":"Hodgkin's disease, nodular sclerosis, intrathoracic lymph nodes"},{"code":"201.53","display":"Hodgkin's disease, nodular sclerosis, intra-abdominal lymph nodes"},{"code":"201.54","display":"Hodgkin's disease, nodular sclerosis, lymph nodes of axilla and upper limb"},{"code":"201.55","display":"Hodgkin's disease, nodular sclerosis, lymph nodes of inguinal region and lower limb"},{"code":"201.56","display":"Hodgkin's disease, nodular sclerosis, intrapelvic lymph nodes"},{"code":"201.57","display":"Hodgkin's disease, nodular sclerosis, spleen"},{"code":"201.58","display":"Hodgkin's disease, nodular sclerosis, lymph nodes of multiple sites"},{"code":"201.60","display":"Hodgkin's disease, mixed cellularity, unspecified site, extranodal and solid organ sites"},{"code":"201.61","display":"Hodgkin's disease, mixed cellularity, lymph nodes of head, face, and neck"},{"code":"201.62","display":"Hodgkin's disease, mixed cellularity, intrathoracic lymph nodes"},{"code":"201.63","display":"Hodgkin's disease, mixed cellularity, intra-abdominal lymph nodes"},{"code":"201.64","display":"Hodgkin's disease, mixed cellularity, lymph nodes of axilla and upper limb"},{"code":"201.65","display":"Hodgkin's disease, mixed cellularity, lymph nodes of inguinal region and lower limb"},{"code":"201.66","display":"Hodgkin's disease, mixed cellularity, intrapelvic lymph nodes"},{"code":"201.67","display":"Hodgkin's disease, mixed cellularity, spleen"},{"code":"201.68","display":"Hodgkin's disease, mixed cellularity, lymph nodes of multiple sites"},{"code":"201.70","display":"Hodgkin's disease, lymphocytic depletion, unspecified site, extranodal and solid organ sites"},{"code":"201.71","display":"Hodgkin's disease, lymphocytic depletion, lymph nodes of head, face, and neck"},{"code":"201.72","display":"Hodgkin's disease, lymphocytic depletion, intrathoracic lymph nodes"},{"code":"201.73","display":"Hodgkin's disease, lymphocytic depletion, intra-abdominal lymph nodes"},{"code":"201.74","display":"Hodgkin's disease, lymphocytic depletion, lymph nodes of axilla and upper limb"},{"code":"201.75","display":"Hodgkin's disease, lymphocytic depletion, lymph nodes of inguinal region and lower limb"},{"code":"201.76","display":"Hodgkin's disease, lymphocytic depletion, intrapelvic lymph nodes"},{"code":"201.77","display":"Hodgkin's disease, lymphocytic depletion, spleen"},{"code":"201.78","display":"Hodgkin's disease, lymphocytic depletion, lymph nodes of multiple sites"},{"code":"201.90","display":"Hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites"},{"code":"201.91","display":"Hodgkin's disease, unspecified type, lymph nodes of head, face, and neck"},{"code":"201.92","display":"Hodgkin's disease, unspecified type, intrathoracic lymph nodes"},{"code":"201.93","display":"Hodgkin's disease, unspecified type, intra-abdominal lymph nodes"},{"code":"201.94","display":"Hodgkin's disease, unspecified type, lymph nodes of axilla and upper limb"},{"code":"201.95","display":"Hodgkin's disease, unspecified type, lymph nodes of inguinal region and lower limb"},{"code":"201.96","display":"Hodgkin's disease, unspecified type, intrapelvic lymph nodes"},{"code":"201.97","display":"Hodgkin's disease, unspecified type, spleen"},{"code":"201.98","display":"Hodgkin's disease, unspecified type, lymph nodes of multiple sites"},{"code":"202.00","display":"Nodular lymphoma, unspecified site, extranodal and solid organ sites"},{"code":"202.01","display":"Nodular lymphoma, lymph nodes of head, face, and neck"},{"code":"202.02","display":"Nodular lymphoma, intrathoracic lymph nodes"},{"code":"202.03","display":"Nodular lymphoma, intra-abdominal lymph nodes"},{"code":"202.04","display":"Nodular lymphoma, lymph nodes of axilla and upper limb"},{"code":"202.05","display":"Nodular lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"202.06","display":"Nodular lymphoma, intrapelvic lymph nodes"},{"code":"202.07","display":"Nodular lymphoma, spleen"},{"code":"202.08","display":"Nodular lymphoma, lymph nodes of multiple sites"},{"code":"202.70","display":"Peripheral T cell lymphoma, unspecified site, extranodal and solid organ sites"},{"code":"202.71","display":"Peripheral T cell lymphoma, lymph nodes of head, face, and neck"},{"code":"202.72","display":"Peripheral T cell lymphoma, intrathoracic lymph nodes"},{"code":"202.73","display":"Peripheral T cell lymphoma, intra-abdominal lymph nodes"},{"code":"202.74","display":"Peripheral T cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"202.75","display":"Peripheral T cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"202.76","display":"Peripheral T cell lymphoma, intrapelvic lymph nodes"},{"code":"202.77","display":"Peripheral T cell lymphoma, spleen"},{"code":"202.78","display":"Peripheral T cell lymphoma, lymph nodes of multiple sites"},{"code":"202.80","display":"Other malignant lymphomas, unspecified site, extranodal and solid organ sites"},{"code":"202.81","display":"Other malignant lymphomas, lymph nodes of head, face, and neck"},{"code":"202.82","display":"Other malignant lymphomas, intrathoracic lymph nodes"},{"code":"202.83","display":"Other malignant lymphomas, intra-abdominal lymph nodes"},{"code":"202.84","display":"Other malignant lymphomas, lymph nodes of axilla and upper limb"},{"code":"202.85","display":"Other malignant lymphomas, lymph nodes of inguinal region and lower limb"},{"code":"202.86","display":"Other malignant lymphomas, intrapelvic lymph nodes"},{"code":"202.87","display":"Other malignant lymphomas, spleen"},{"code":"202.88","display":"Other malignant lymphomas, lymph nodes of multiple sites"},{"code":"202.90","display":"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, unspecified site, extranodal and solid organ sites"},{"code":"203.00","display":"Multiple myeloma, without mention of having achieved remission"},{"code":"203.02","display":"Multiple myeloma, in relapse"},{"code":"203.10","display":"Plasma cell leukemia, without mention of having achieved remission"},{"code":"203.12","display":"Plasma cell leukemia, in relapse"},{"code":"204.00","display":"Acute lymphoid leukemia, without mention of having achieved remission"},{"code":"204.02","display":"Acute lymphoid leukemia, in relapse"},{"code":"204.12","display":"Chronic lymphoid leukemia, in relapse"},{"code":"204.20","display":"Subacute lymphoid leukemia, without mention of having achieved remission"},{"code":"204.22","display":"Subacute lymphoid leukemia, in relapse"},{"code":"204.80","display":"Other lymphoid leukemia, without mention of having achieved remission"},{"code":"204.82","display":"Other lymphoid leukemia, in relapse"},{"code":"204.90","display":"Unspecified lymphoid leukemia, without mention of having achieved remission"},{"code":"204.92","display":"Unspecified lymphoid leukemia, in relapse"},{"code":"205.00","display":"Acute myeloid leukemia, without mention of having achieved remission"},{"code":"205.02","display":"Acute myeloid leukemia, in relapse"},{"code":"205.10","display":"Chronic myeloid leukemia, without mention of having achieved remission"},{"code":"205.12","display":"Chronic myeloid leukemia, in relapse"},{"code":"205.20","display":"Subacute myeloid leukemia, without mention of having achieved remission"},{"code":"205.22","display":"Subacute myeloid leukemia, in relapse"},{"code":"205.80","display":"Other myeloid leukemia, without mention of having achieved remission"},{"code":"205.82","display":"Other myeloid leukemia, in relapse"},{"code":"205.90","display":"Unspecified myeloid leukemia, without mention of having achieved remission"},{"code":"205.92","display":"Unspecified myeloid leukemia, in relapse"},{"code":"206.00","display":"Acute monocytic leukemia, without mention of having achieved remission"},{"code":"206.02","display":"Acute monocytic leukemia, in relapse"},{"code":"206.10","display":"Chronic monocytic leukemia, without mention of having achieved remission"},{"code":"206.12","display":"Chronic monocytic leukemia, in relapse"},{"code":"206.20","display":"Subacute monocytic leukemia, without mention of having achieved remission"},{"code":"206.22","display":"Subacute monocytic leukemia, in relapse"},{"code":"206.80","display":"Other monocytic leukemia, without mention of having achieved remission"},{"code":"206.82","display":"Other monocytic leukemia, in relapse"},{"code":"206.90","display":"Unspecified monocytic leukemia, without mention of having achieved remission"},{"code":"206.92","display":"Unspecified monocytic leukemia, in relapse"},{"code":"207.20","display":"Megakaryocytic leukemia, without mention of having achieved remission"},{"code":"207.22","display":"Megakaryocytic leukemia, in relapse"},{"code":"207.80","display":"Other specified leukemia, without mention of having achieved remission"},{"code":"207.82","display":"Other specified leukemia, in relapse"},{"code":"208.00","display":"Acute leukemia of unspecified cell type, without mention of having achieved remission"},{"code":"208.02","display":"Acute leukemia of unspecified cell type, in relapse"},{"code":"208.10","display":"Chronic leukemia of unspecified cell type, without mention of having achieved remission"},{"code":"208.12","display":"Chronic leukemia of unspecified cell type, in relapse"},{"code":"208.20","display":"Subacute leukemia of unspecified cell type, without mention of having achieved remission"},{"code":"208.22","display":"Subacute leukemia of unspecified cell type, in relapse"},{"code":"208.80","display":"Other leukemia of unspecified cell type, without mention of having achieved remission"},{"code":"208.82","display":"Other leukemia of unspecified cell type, in relapse"},{"code":"208.90","display":"Unspecified leukemia, without mention of having achieved remission"},{"code":"208.92","display":"Unspecified leukemia, in relapse"},{"code":"238.75","display":"Myelodysplastic syndrome, unspecified"},{"code":"279.51","display":"Acute graft-versus-host disease"},{"code":"279.53","display":"Acute on chronic graft-versus-host disease"},{"code":"284.11","display":"Antineoplastic chemotherapy induced pancytopenia"},{"code":"284.12","display":"Other drug-induced pancytopenia"},{"code":"284.19","display":"Other pancytopenia"},{"code":"288.00","display":"Neutropenia, unspecified"},{"code":"288.01","display":"Congenital neutropenia"},{"code":"288.02","display":"Cyclic neutropenia"},{"code":"288.03","display":"Drug induced neutropenia"},{"code":"288.04","display":"Neutropenia due to infection"},{"code":"288.09","display":"Other neutropenia"},{"code":"289.53","display":"Neutropenic splenomegaly"}]}]}}